PDX Resource

The HCI-Baylor College of Medicine Patient-derived Xenograft Development and Trials Center(PDTC) is a multi-institutional Center comprising three well-established research groups: two from the Huntsman Cancer Institute (HCI) at the University of Utah, and one from Baylor College of Medicine (BCM). The HCI-BCM PDTC focuses on breast cancer, with 76 patient-derived xenografts (PDX) lines immediately available for Supplement proposals. ... Read more

Cancer by System

Data Available